Zambia Center for Applied Health Research and Development Report issue

Government Phase 3

Organization Overview

First Clinical Trial
2011
NCT01241318
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

chlorhexidine (hibitane) (2 trials)

Drugs in Other Trials (1)

ethanol (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2